Literature DB >> 20444510

Respiratory muscle dysfunction in congestive heart failure--the role of pulmonary hypertension.

Arthur Filusch1, Ralf Ewert, Maike Altesellmeier, Christian Zugck, Roland Hetzer, Mathias M Borst, Hugo A Katus, F Joachim Meyer.   

Abstract

BACKGROUND: Inspiratory muscle weakness has been described in patients with congestive heart failure (CHF), and only recently in patients with idiopathic pulmonary arterial hypertension. However, the relationship between pulmonary hemodynamics and respiratory muscle function has not been investigated in patients with CHF. METHODS AND
RESULTS: In two tertial referral centers for CHF patients, 532 consecutive CHF patients (159 female, age 59 ± 12 years, NYHA I-IV) were studied by right heart catheterization, maximal inspiratory mouth occlusion pressure (Pi(max)) and pressure 0.1s after beginning of inspiration during tidal breathing at rest (P(0.1)). There was a significant correlation between Pi(max) and mean pulmonary artery pressure (PAPm) (r=-0.65, p=0.0023), mean pulmonary capillary wedge pressure (PCWPm) (r=-0.56; p=0.0018), PVR (r=-0.73; p=0.0031), and cardiac output (r=0.51; p=0.0022). Moreover, the ratio P(0.1)/Pi(max) showed a linear correlation with PAPm (r=0.54; p=0.0019), and with TPG (r=0.64; p=0.0014) respectively. Vital capacity was reduced in relation to increased PAPm (r=-0.54; p=0.0029). Pi(max) and P(0.1)/Pi(max) were independent from VC.
CONCLUSIONS: This study provides the first evidence of a close relation between inspiratory muscle dysfunction, increased ventilatory drive and pulmonary hypertension in a large patient cohort with CHF. Pi(max) and P(0.1) can easily be measured in clinical routine and might become an additional parameter for the non-invasive monitoring of the hemodynamic severity of disease.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20444510     DOI: 10.1016/j.ijcard.2010.04.006

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  11 in total

1.  Biological variation, reference change value (RCV) and minimal important difference (MID) of inspiratory muscle strength (PImax) in patients with stable chronic heart failure.

Authors:  Tobias Täger; Miriam Schell; Rita Cebola; Hanna Fröhlich; Andreas Dösch; Jennifer Franke; Hugo A Katus; Frank H Wians; Lutz Frankenstein
Journal:  Clin Res Cardiol       Date:  2015-04-18       Impact factor: 5.460

2.  Diaphragm weakness and proteomics (global and redox) modifications in heart failure with reduced ejection fraction in rats.

Authors:  Rachel C Kelley; Brian McDonagh; Babette Brumback; Glenn A Walter; Ravneet Vohra; Leonardo F Ferreira
Journal:  J Mol Cell Cardiol       Date:  2020-02-05       Impact factor: 5.000

3.  NAD(P)H oxidase subunit p47phox is elevated, and p47phox knockout prevents diaphragm contractile dysfunction in heart failure.

Authors:  Bumsoo Ahn; Adam W Beharry; Gregory S Frye; Andrew R Judge; Leonardo F Ferreira
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-07-24       Impact factor: 5.464

4.  Reduced force of diaphragm muscle fibers in patients with chronic thromboembolic pulmonary hypertension.

Authors:  Emmy Manders; Peter I Bonta; Jaap J Kloek; Petr Symersky; Harm-Jan Bogaard; Pleuni E Hooijman; Jeff R Jasper; Fady I Malik; Ger J M Stienen; Anton Vonk-Noordegraaf; Frances S de Man; Coen A C Ottenheijm
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-05-17       Impact factor: 5.464

Review 5.  Diaphragm abnormalities in heart failure and aging: mechanisms and integration of cardiovascular and respiratory pathophysiology.

Authors:  Rachel C Kelley; Leonardo F Ferreira
Journal:  Heart Fail Rev       Date:  2017-03       Impact factor: 4.214

6.  Pharmacological targeting of mitochondrial reactive oxygen species counteracts diaphragm weakness in chronic heart failure.

Authors:  Orlando Laitano; Bumsoo Ahn; Nikhil Patel; Philip D Coblentz; Ashley J Smuder; Jeung-Ki Yoo; Demetra D Christou; Peter J Adhihetty; Leonardo F Ferreira
Journal:  J Appl Physiol (1985)       Date:  2016-02-04

7.  Research on cachexia, sarcopenia and skeletal muscle in cardiology.

Authors:  Andrew J S Coats
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-11-16       Impact factor: 12.910

8.  Relation of respiratory muscle strength, cachexia and survival in severe chronic heart failure.

Authors:  Dirk Habedank; F Joachim Meyer; Roland Hetzer; Stefan D Anker; Ralf Ewert
Journal:  J Cachexia Sarcopenia Muscle       Date:  2013-06-21       Impact factor: 12.910

9.  Diaphragm Abnormalities in Patients with End-Stage Heart Failure: NADPH Oxidase Upregulation and Protein Oxidation.

Authors:  Bumsoo Ahn; Philip D Coblentz; Adam W Beharry; Nikhil Patel; Andrew R Judge; Jennifer S Moylan; Charles W Hoopes; Mark R Bonnell; Leonardo F Ferreira
Journal:  Front Physiol       Date:  2017-01-09       Impact factor: 4.566

10.  The conventional isoproterenol-induced heart failure model does not consistently mimic the diaphragmatic dysfunction observed in patients.

Authors:  Ignacio Cabrera-Aguilera; Bryan Falcones; Alicia Calvo-Fernández; Begoña Benito; Esther Barreiro; Joaquim Gea; Ramon Farré; Isaac Almendros; Núria Farré
Journal:  PLoS One       Date:  2020-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.